Brian Otis, Google X Project Manager, has a contact line Google tested to investigate tear glucose in 2014. Photo: Jeff Chiu (AP)
The alphabet has stopped a project during its biotechnology division. to create smart contact lenses for people with diabetes. The ambitious yearlong pursuit aimed at measuring glucose levels in tears with the help of lens sensors.
Probably the announcement made a blog post on Friday’s decision with Alcon to present the project in the foreseeable future, referring to inconsistencies in its measurements between blood and tear glucose levels. (Certainly cooperated with the Swiss Eye Care Company, a Novartis subsidiary, 2014 to develop glucose-sensitive contacts.)
“Our clinical work on glucose-sensitive lens showed that there was insufficient consistency in our measurements of correlation between tear glucose and blood glucose concentrations to support the requirement for a medical device, “says the company.” Partly, this was associated with the challenges of obtaining reliable tear glucose readings in the complex eye environment. “
Probably said it would continue to collaborate with Alcon on its two other Smart Lens devices: one intraocular lens designed to improve vision for cataract surgery and another for presbyopia. Alcon confirmed that the decision to stop the project was mutual.
It is a remarkable move for the company and one that was not without its warning signs. Experts and Google employees have previously criticized the project, me d Stat Reporting 2016 that a former Verily manager described the smart lens as “slides” or a project that sounds good in theory but is limited in its potential beyond a PowerPoint presentation.  Defended its technology and research at that time, Verily told State: “Like with true innovation, some projects may fail.” Still, Friday is committed to its other diabetes-related projects, including other affordable and discreet glucose-sensing methods.
[Verily via CNBC]